Sarepta Therapeutics (NQ: SRPT )
141.31
+4.03
(+2.93%)
Streaming Delayed Price
Updated: 12:33 PM EDT, Aug 20, 2024
Add to My Watchlist
Headline News about Sarepta Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About Sarepta Therapeutics?
August 16, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/785759/physician-giving-medicine-to-elderly-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/08/11/Monster-Energy-logo.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Smart Money Is Betting Big In SRPT Options
August 08, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp)
NASDAQ:SRPT may be ready to breakout.
August 02, 2024
Via Chartmill
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
26 Analysts Have This To Say About Sarepta Therapeutics
July 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/12/Stock-aviditybiosciences-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/08/08/McKesson.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript
August 08, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://investorplace.com/wp-content/uploads/2024/06/srpt1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/sava-stock-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/17/Jim-Cramer-Photo-by-s-bukley-on-Shutters.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/781823/doctor-and-businessman-working-on-digital-tablet-in-the-office.jpg)
![](https://g.foolcdn.com/editorial/images/782122/a-doctor-looking-at-a-tablet-with-another-person.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/781683/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://g.foolcdn.com/editorial/images/781349/business-people-and-doctors-talking-on-a-meeting-in-hospital.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/23/draftkings-shutter3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/03/ibdstocksupdate5.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.